CONGRESS NEWS

Post ASCO GU regional tour

BJMO - volume 14, issue 3, may 2020

No authors

Read more

Highlights of the Gastrointestinal Cancers Symposium 2020

BJMO - volume 14, issue 3, may 2020

No authors

SUMMARY

At the background of the Golden Gate Bridge with a view on the Pacific Ocean, the annual Gastrointestinal Cancers Symposium was held from 23rd until 25th January 2020 in the Moscone Congress Center in San Francisco, California. During this meeting, the potential of immunotherapy in the treatment of cancers from the upper and lower digestive tract was discussed, but no major breakthroughs were presented this year. In addition to immunotherapy, ASCO GI 2020 featured several interesting presentations on the molecular profiling of different types of gastro-intestinal cancers. These increased molecular insights will hopefully pave the way for a more biomarker-driven treatment approach for these tumours in the near future. In this report, the most important headlines will be discussed, with comments on the clinical relevance of the different studies.

(BELG J MED ONCOL 2020;14(3):116–25)

Read more

Geriatric oncology: Integrative Oncology – Leaving no one behind

BJMO - volume 14, issue 3, may 2020

No authors

SUMMARY

The 2019 annual conference of the International Society of Geriatric Oncology took place in Geneva, Switzerland from November 14–16th. This year, the International Society of Geriatric Oncology and the International Federation on Ageing also jointly hosted a meeting at the United Nations on the development and preparation of health care professionals for the ageing population with cancer.

(BELG J MED ONCOL 2020;14(3):114–5)

Read more

3rd Annual International Oncology Leadership Conference

BJMO - volume 14, issue 2, march 2020

D. Verhoeven MD, PhD, A. Paravati MBA, MD

SUMMARY

The annual International Oncology Leadership Conference (IOLC) brings together physicians and administrative professionals from around the world to share best practices and to discuss future trends and challenges affecting the provision of cancer care. Following prior IOLC meetings in London and Milan, the conference in 2019 took place in Antwerp. Chairperson Prof. Didier Verhoeven and the planning committee organised an engaging agenda which was divided into three parts: economy, technology, and patient engagement/leadership. One of the main purposes of this conference is to compare US and European approaches and to learn from each other. Attendees from thirteen countries participated at the IOLC 2019. IOLC is presented by the Association of Cancer Executives and in partnership with Hauck & Associates, Inc. Some interesting points of the meeting are mentioned below.

(BELG J MED ONCOL 2020;14(2):84–5)

Read more

The 13th Belgian symposium on the integration of molecular biology advances into oncology clinical practice (BSMO/Bordet meeting)

BJMO - volume 14, issue 1, january 2020

J. Blokken PhD, PharmD, T. Feys MBA, MSc

SUMMARY

On the 22nd and 23rd of November 2019, the Jules Bordet Institute and the Belgian Society of Medical Oncology (BSMO) hosted the 13th Belgian symposium on the integration of molecular biology advances into oncology clinical practice. In the course of the symposium, a fine selection of Belgian and international key opinion leaders discussed the clinical impact of molecular biology advances in a plethora of cancer types.

(BELG J MED ONCOL 2020;14(1):31–41)

Read more

2019 World Conference on Lung Cancer

BJMO - volume 13, issue 7, november 2019

T. Feys MBA, MSc

SUMMARY

From 7–10th of September, the 2019 World Conference on Lung Cancer (WCLC) again proved to be the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. The meeting attracted more than 7,000 specialists from more than 100 countries. In this highlight report ten top abstracts presented at the meeting will be discussed. For a more complete coverage of the meeting we refer to the congress website: https://wclc2019.iaslc.org.

(BELG J MED ONCOL 2019;13(7):309–13)

Read more

EAU19: New developments in PCa imaging and trials

BJMO - volume 13, issue 7, november 2019

H. Van Poppel MD, PhD

SUMMARY

The European Association of Urology (EAU) held its 34th Annual Congress in Barcelona from the 15–19th of March, a recurring highlight for the Association and for urology in general. While the presenting of the latest EAU Guidelines, holding meetings for its Board and Sections and setting agendas for the coming year are essential to the running of the Association, it is the latest scientific developments in urology that took centre stage in Barcelona.

Scientific Congress Office Chairman Prof Arnulf Stenzl (DE) presided over the scientific programme one last time, stepping down to join the EAU Executive as Adjunct Secretary General (Science). He was congratulated on his track record and particularly the comprehensive and diverse five-day programme that greeted the nearly 12,000 participants from 127 countries in Barcelona.

This article provides some uro-oncological highlights from the 263 different scientific sessions at EAU19. For the most complete coverage, see the on-site news reports on www.eau19.org/news.

(BELG J MED ONCOL 2019;13(7):314–6)

Read more